Cardiff Oncology Ownership | Who Owns Cardiff Oncology?
Cardiff Oncology Ownership Summary
Cardiff Oncology is owned by 2.24% institutional investors, 5.64% insiders, and 92.12% retail investors. Commodore capital lp is the largest institutional shareholder, holding 8.09% of CRDF shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.19% of its assets in Cardiff Oncology shares.
CRDF Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Cardiff Oncology | 2.24% | 5.64% | 92.12% |
| Sector | Healthcare Stocks | 279.18% | 10.62% | -189.80% |
| Industry | Biotech Stocks | 63.96% | 10.74% | 25.30% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Commodore capital lp | 5.38M | 8.09% | $16.91M |
| Blackrock funding, inc. /de | 2.84M | 6.06% | $12.33M |
| Blackrock | 2.63M | 5.88% | $5.84M |
| Pfizer | 2.41M | 5.15% | $10.47M |
| Vanguard group | 2.28M | 4.88% | $9.92M |
| Adage capital partners gp | 1.29M | 2.76% | $5.61M |
| Geode capital management | 982.88K | 2.10% | $4.27M |
| Mai capital management | 916.59K | 1.96% | $3.98M |
| State street | 848.58K | 1.81% | $3.68M |
| Nuveen asset management | 586.62K | 1.25% | $2.55M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Commodore capital lp | 5.38M | 1.25% | $16.91M |
| Pfizer | 2.41M | 0.40% | $10.47M |
| Caxton | 13.29K | 0.35% | $57.66K |
| Dafna capital management | 150.00K | 0.13% | $471.00K |
| Gsa capital partners llp | 380.07K | 0.12% | $1.65M |
| Elkhorn partners limited partnership | 32.00K | 0.09% | $139.00K |
| Avestar capital | 140.47K | 0.05% | $609.63K |
| Findec wealth services | 16.00K | 0.05% | $69.44K |
| Laurion capital management lp | 576.92K | 0.05% | $2.50M |
| Orbimed advisors | 573.88K | 0.04% | $1.80M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Pfizer | 2.41M | 0.40% | 2.41M |
| Blackrock | 2.63M | 0.00% | 1.95M |
| Adage capital partners gp | 1.29M | 0.01% | 1.29M |
| Laurion capital management lp | 576.92K | 0.05% | 576.92K |
| Morgan stanley | 513.22K | 0.00% | 433.80K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Orbimed advisors | 573.88K | 0.04% | -964.58K |
| Point72 asset management | - | - | -508.44K |
| Ikarian capital | - | - | -450.00K |
| Two sigma advisers, lp | 14.80K | 0.00% | -316.40K |
| Assenagon asset management | 67.23K | 0.00% | -203.29K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Pfizer | 2.41M | 0.40% | 2.41M | $10.47M |
| Adage capital partners gp | 1.29M | 0.01% | 1.29M | $5.61M |
| Laurion capital management lp | 576.92K | 0.05% | 576.92K | $2.50M |
| Dafna capital management | 150.00K | 0.13% | 150.00K | $471.00K |
| Virtu financial | 51.18K | 0.01% | 51.18K | $222.00K |
Sold Out
| Holder | Change |
|---|---|
| Newbridge financial services group | -17.00 |
| Eagle bay advisors | -339.00 |
| Macquarie group | -1.37K |
| Pnc financial services group | -1.52K |
| America first investment advisors | -4.00K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | 7 | -94.44% | 1,488,712 | -94.70% | 2 | 0.06% | 4 | -94.87% | 1 | -93.33% |
| Dec 31, 2024 | 121 | 35.96% | 27,910,732 | 118.71% | 59 | 8.03% | 73 | 114.71% | 15 | -37.50% |
| Sep 30, 2024 | 88 | -8.33% | 12,508,364 | -2.23% | 26 | 3.25% | 34 | -45.16% | 23 | 109.09% |
| Jun 30, 2024 | 96 | 17.07% | 12,794,219 | 52.97% | 28 | 8.17% | 62 | 40.91% | 11 | - |
| Mar 31, 2024 | 82 | 41.38% | 8,363,780 | 57.97% | 18 | 13.33% | 44 | 214.29% | 11 | -21.43% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 2.13M | 3.19% | 601.17K |
| iShares Russell 2000 ETF | 1.50M | 2.26% | 735.00 |
| Vanguard US Total Market Shares ETF | 1.25M | 1.89% | - |
| CREF Stock R1 | 1.25M | 1.87% | 17.50K |
| Vanguard Institutional Extnd Mkt Idx Tr | 992.76K | 1.49% | - |
| CREF Stock R3 | 781.91K | 1.18% | -464.77K |
| Fidelity Small Cap Index | 407.99K | 0.61% | 7.12K |
| Fidelity Extended Market Index | 339.99K | 0.51% | 83.92K |
| iShares Russell 2000 Value ETF | 323.24K | 0.49% | - |
| Vanguard Russell 2000 ETF | 287.90K | 0.43% | 16.12K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Dec 16, 2024 | Levine James E. | Chief Financial Officer | Buy | $9.82K |
| Dec 17, 2024 | Levine James E. | Chief Financial Officer | Buy | $14.91K |
| Dec 18, 2024 | Levine James E. | Chief Financial Officer | Buy | $12.00K |
| Dec 12, 2024 | TANNENBAUM RENEE P | - | Buy | $34.22K |
| Dec 11, 2024 | PACE GARY W | - | Buy | $29.90K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q1 | - | - |
| 2024 Q4 | 6 | - |
| 2024 Q2 | - | - |
| 2024 Q1 | - | - |
| 2023 Q4 | 2 | - |
CRDF Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools